Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement-activating abilities of defined antinuclear antibodies.

Y Kanayama, C Peebles, E M Tan

    Arthritis and Rheumatism
    |June 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Electroconvulsive therapy for catatonia secondary to neuroleptic malignant syndrome in a patient with multiple sclerosis.

    The Australian and New Zealand journal of psychiatry·2019
    Same author

    Erysipelothrix rhusiopathiae bloodstream infection - A 22-year experience at Mayo Clinic, Minnesota.

    Zoonoses and public health·2017
    Same author

    Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules-the SPUtNIk study.

    BMJ open respiratory research·2016
    Same author

    Ledipasvir/sofosbuvir fixed-dose combination for treatment of hepatitis C virus genotype 4 infection.

    Drugs of today (Barcelona, Spain : 1998)·2016
    Same author

    MRI in adult patients with aortic coarctation: diagnosis and follow-up.

    Clinical radiology·2015
    Same author

    Troponin-positive chest pain with unobstructed coronary arteries: definitive differential diagnosis using cardiac MRI.

    The British journal of radiology·2012
    Same journal

    Proceedings of the Annual Meeting of the American Rheumatism Association.

    Arthritis and rheumatism·2020
    Same journal

    The regional distribution of rheumatologists: what can we do, what should we do?

    Arthritis and rheumatism·2013
    Same journal

    Regional distribution of adult rheumatologists.

    Arthritis and rheumatism·2013
    Same journal

    Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

    Arthritis and rheumatism·2013
    Same journal

    Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

    Arthritis and rheumatism·2013
    Same journal

    Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

    Arthritis and rheumatism·2013
    See all related articles

    Different antinuclear antibodies (ANA) vary in their ability to activate complement. Nuclear RNP-anti-RNP complexes showed the highest complement C3 activation, while antihistone antibodies showed the least.

    Area of Science:

    • Immunology
    • Rheumatology
    • Cell Biology

    Background:

    • Antinuclear antibodies (ANA) are key biomarkers in autoimmune diseases.
    • The complement system plays a crucial role in immune responses and inflammation.
    • Understanding ANA's complement-activating potential is vital for disease pathogenesis insights.

    Purpose of the Study:

    • To quantify and compare the complement-activating capabilities of various specific ANA.
    • To determine the hierarchy of complement activation by different ANA specificities.

    Main Methods:

    • A complement-fixing immunofluorescence assay using HEp-2 cells was employed.
    • Sera with specific antibodies (nuclear RNP, SS-B/La, centromere, Sm, dsDNA, histone) were selected.
    • Complement activation was assessed by comparing C3, C4, or properdin-fixing ANA titers to IgG ANA titers.

    Related Experiment Videos

    Main Results:

    • Nuclear RNP-anti-RNP complexes demonstrated significantly higher complement C3 activation compared to other ANA (P < 0.02).
    • Antibodies to SS-B/La, centromere, and Sm activated complement more effectively than anti-DNA or antihistone antibodies (P < 0.02).
    • Antihistone antibodies exhibited the lowest complement-activating capacity.

    Conclusions:

    • Distinct ANA specificities possess significantly different orders of complement-activating potential.
    • ANA-mediated complement activation varies based on the specific nuclear antigen targeted.
    • These findings contribute to understanding the immunopathology of autoimmune diseases driven by ANA.